BPA CALL
Active36C26027N0034
Department of Veterans Affairs › 260-NETWORK CONTRACT OFFICE 20 (36C260)
$1.6M
obligated · signed 6 days ago
PYLARIFY TRUVU (PIFLUFOLASTAT F18) INJECTIONS
Performance timeline
Start
Nov 1, 2026
End
Oct 31, 2027
with all options
Loading status
Estimated start: Oct 31, 2026
PROGENICS PHARMACEUTICALS INC
Contract 36C26027N0034
UEI
YLYKVRPCTCR3
Parent Company
LANTHEUS HOLDINGS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$1,623,924
Base + Exercised Options
$1,623,924
Total Ceiling Value
$1,623,924
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
260-NETWORK CONTRACT OFFICE 20 (36C260)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
663-SEATTLE (00663)
Office
Contract Vehicle
36C26027A0001
BPADepartment of Veterans Affairs
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.